Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

OBJECTIVE: GH replacement is widely used in the management of patients with adult-onset (AO)-GH deficiency (GHD). In most cases, AO-GHD arises as a result of pituitary/peripituitary tumours and/or their treatment, but the effect of GH replacement on recurrence/regrowth of these tumours is unknown. T...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Chung, T, Drake, WM, Evanson, J, Walker, D, Plowman, P, Chew, S, Grossman, AB, Besser, G, Monson, J
Format:	Journal article
Sprache:	English
Veröffentlicht:	2005

Ähnliche Einträge

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
von: Chung, T, et al.
Veröffentlicht: (2008)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
von: Swords, F, et al.
Veröffentlicht: (2009)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
von: Frajese, G, et al.
Veröffentlicht: (2001)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
von: Chung, T, et al.
Veröffentlicht: (2010)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
von: Colson, A, et al.
Veröffentlicht: (2008)

Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen.
von: Janmohamed, S, et al.
Veröffentlicht: (2002)

Intracardiac metastases from neuroendocrine tumours.
von: Drake, WM, et al.
Veröffentlicht: (1997)

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
von: Kaltsas, G, et al.
Veröffentlicht: (2002)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
von: Agha, A, et al.
Veröffentlicht: (2007)

MRI of pancreatic neuroendocrine tumours.
von: Owen, N, et al.
Veröffentlicht: (2001)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
von: Colson, A, et al.
Veröffentlicht: (2006)

Second brain tumour after treatment for pituitary adenoma.
von: Wass, J, et al.
Veröffentlicht: (1992)

The diagnosis and management of parasellar tumours of the pituitary.
von: Kaltsas, G, et al.
Veröffentlicht: (2008)

The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
von: Kaltsas, G, et al.
Veröffentlicht: (2001)

Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin.
von: Ewan A Langan, et al.
Veröffentlicht: (2013-01-01)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
von: Drake, WM, et al.
Veröffentlicht: (1998)

The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
von: Kaltsas, G, et al.
Veröffentlicht: (2001)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
von: Mukherjee, J, et al.
Veröffentlicht: (2001)

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
von: Srirangalingam, U, et al.
Veröffentlicht: (2009)

Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
von: Blacklay, A, et al.
Veröffentlicht: (1986)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
von: le Roux, C, et al.
Veröffentlicht: (2002)

Update on neuroendocrine tumours
von: Grossman, AB
Veröffentlicht: (2012)

Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
von: Carroll, P, et al.
Veröffentlicht: (2004)

Ectopic Posterior Pituitary and Its Associations with Extrapituitary Intracranial Anomalies
von: Alamelu Alagappan, et al.
Veröffentlicht: (2024-10-01)

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
von: Carroll, P, et al.
Veröffentlicht: (2003)

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
von: Swords, F, et al.
Veröffentlicht: (2003)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
von: Monson, J, et al.
Veröffentlicht: (2001)

Malignant pituitary tumours.
von: Kaltsas, G, et al.
Veröffentlicht: (1998)

Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
von: Kaltsas, G, et al.
Veröffentlicht: (2000)

Intra-abdominal fibrosis in a modern cohort of patients with mid-gut carcinoid tumours - a cross-sectional survey from one centre
von: Druce, MR, et al.
Veröffentlicht: (2009)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
von: Kaltsas, G, et al.
Veröffentlicht: (1998)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
von: Gupta, P, et al.
Veröffentlicht: (2014)

Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel.
von: Druce, MR, et al.
Veröffentlicht: (2010)

The molecular pathogenesis of corticotroph tumours.
von: Dworakowska, D, et al.
Veröffentlicht: (2012)

Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
von: Sen Gupta, P, et al.
Veröffentlicht: (2014)

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
von: Florakis, D, et al.
Veröffentlicht: (2000)

Medical therapy of pituitary tumours: What is on the horizon?
von: Grossman, AB
Veröffentlicht: (2010)

Commentary: imaging of islet-cell tumours.
von: Grossman, AB, et al.
Veröffentlicht: (2005)

Morbidity in patients on long-term steroid replacement therapy.
von: Druce, MR, et al.
Veröffentlicht: (2010)

Extrapituitary prolactin –1149 G/T promoter polymorphism in some rheumatoid arthritis patients
von: Adnan F. AL-Azzawie
Veröffentlicht: (2015-06-01)